Orion’s Virtual Capital Markets Day today at 13.00 EEST – presentation material now available

ORION CORPORATION INVESTOR NEWS 26 MAY 2021 at 10.15 EEST

Orion’s Virtual Capital Markets Day today at 13.00 EEST – presentation material now available

Orion will arrange a virtual Capital Markets Day 2021 for investors, analysts and media today 13:00–16:00 EEST. The presentation material is now available on Orion’s website at https://www.orion.fi/en/cmd-2021

At the event, Orion's management will provide an update on the company's strategy and targets, business and research & development projects. The presentations are divided into two main themes which are ‘Creating growth towards 2025 target and beyond’ and ‘Creating long-term value’.

Speakers and programme

Main theme	Speaker
Orion’s strategy and introduction	Timo Lappalainen, President & CEO
Creating growth towards 2025 target and beyond	Satu Ahomäki, SVP, Proprietary Products and Commercial Operations
	Niclas Lindstedt, VP, Animal Health
	Virve Laitinen, SVP, Specialty Products
	Jari Karlson, CFO
Creating long-term value
	Outi Vaarala, SVP, Research & Development
	Liisa Hurme, SVP, Global Operations
Conclusions	Timo Lappalainen, President & CEO

Participants of the Capital Markets Day are kindly asked to register for the event through this link. Participants will have the opportunity to ask questions from Orion’s management during the event.

Contact person:

Tuukka Hirvonen, Investor Relations, Orion Corporation
Tel. +358 10 426 2721

Publisher:
Orion Corporation
Communications
Orionintie 1A, FI-02200 Espoo, Finland
www.orion.fi

Orion is a globally operating Finnish pharmaceutical company – a builder of well-being. Orion develops, manufactures and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company is continuously developing new drugs and treatment methods. The core therapy areas of Orion's pharmaceutical R&D are neurological disorders, oncology and respiratory diseases for which Orion develops inhaled pulmonary medication. Orion's net sales in 2020 amounted to EUR 1,078 million and the company had about 3,300 employees at the end of the year. Orion's A and B shares are listed on Nasdaq Helsinki.